• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Relationship between platelet reactivity inhibition and non-CABG related major bleeding in patients undergoing percutaneous coronary intervention.

作者信息

Mokhtar Omar Ait, Lemesle Gilles, Armero Sébastien, Mancini Julien, Bonello Caroline, Tahirou Iliassou, Barragan Paul, Dignat-George Françoise, Camoin-Jau Laurence, Paganelli Franck, Bonello Laurent

出版信息

Thromb Res. 2010 Aug;126(2):e147-9. doi: 10.1016/j.thromres.2010.01.013. Epub 2010 Feb 2.

DOI:10.1016/j.thromres.2010.01.013
PMID:20129650
Abstract
摘要

相似文献

1
Relationship between platelet reactivity inhibition and non-CABG related major bleeding in patients undergoing percutaneous coronary intervention.接受经皮冠状动脉介入治疗的患者中血小板反应性抑制与非冠状动脉旁路移植术相关的大出血之间的关系。
Thromb Res. 2010 Aug;126(2):e147-9. doi: 10.1016/j.thromres.2010.01.013. Epub 2010 Feb 2.
2
Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.氯吡格雷用于冠心病患者的获益与风险：来自随机研究和注册登记研究的证据
Clin Ther. 2008;30 Pt 2:2191-202. doi: 10.1016/j.clinthera.2008.12.001.
3
Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.氯吡格雷与阿司匹林联合应用于非ST段抬高型急性冠状动脉综合征患者外科血运重建的获益与风险：氯吡格雷用于不稳定型心绞痛预防再发缺血事件（CURE）试验
Circulation. 2004 Sep 7;110(10):1202-8. doi: 10.1161/01.CIR.0000140675.85342.1B. Epub 2004 Aug 16.
4
Comparison of methods to evaluate clopidogrel-mediated platelet inhibition after percutaneous intervention with stent implantation.经皮冠状动脉介入术植入支架后评估氯吡格雷介导的血小板抑制作用的方法比较。
Thromb Haemost. 2009 Feb;101(2):333-9.
5
Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy.普拉格雷与氯吡格雷对未植入支架行经皮冠状动脉介入治疗的急性冠脉综合征患者预后的影响：一项通过优化血小板抑制作用评估普拉格雷改善治疗转归的试验（TRITON）-心肌梗死溶栓试验（TIMI）38亚组研究
Am Heart J. 2009 Sep;158(3):e21-6. doi: 10.1016/j.ahj.2009.06.021.
6
Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?接受氯吡格雷长期治疗的高血小板聚集患者在接受经皮冠状动脉介入治疗时风险增加：当前的抗血小板治疗是否足够？
J Am Coll Cardiol. 2007 Feb 13;49(6):657-66. doi: 10.1016/j.jacc.2006.10.050. Epub 2007 Jan 26.
7
Comparison of platelet reactivity and periprocedural outcomes in patients with versus without diabetes mellitus and treated with clopidogrel and percutaneous coronary intervention.比较伴或不伴糖尿病且接受氯吡格雷和经皮冠状动脉介入治疗的患者的血小板反应性和围手术期结局。
Am J Cardiol. 2010 Sep 1;106(5):619-23. doi: 10.1016/j.amjcard.2010.04.015.
8
Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial.在计划进行经皮冠状动脉介入治疗的患者中，普拉格雷与高负荷及维持剂量氯吡格雷的比较：心肌梗死溶栓治疗44试验中普拉格雷与氯吡格雷抑制血小板活化和聚集的比较。
Circulation. 2007 Dec 18;116(25):2923-32. doi: 10.1161/CIRCULATIONAHA.107.740324. Epub 2007 Dec 3.
9
Patients with non-ST-elevation acute coronary syndromes undergoing coronary artery bypass grafting in the modern era of antithrombotic therapy.在抗血栓治疗的现代时代接受冠状动脉旁路移植术的非ST段抬高型急性冠状动脉综合征患者。
Am Heart J. 2008 Feb;155(2):239-44. doi: 10.1016/j.ahj.2007.10.002. Epub 2007 Nov 26.
10
Persistent platelet activation is related to very early cardiovascular events in patients with acute coronary syndromes.持续性血小板活化与急性冠状动脉综合征患者的极早期心血管事件相关。
Kardiol Pol. 2007 Jan;65(1):40-5; discussion 46.

引用本文的文献

1
Similar Inflammatory Biomarkers Reflect Different Platelet Reactivity in Percutaneous Coronary Intervention Patients Treated With Clopidogrel: A Large-Sample Study From China.相似的炎症生物标志物反映接受氯吡格雷治疗的经皮冠状动脉介入治疗患者不同的血小板反应性：一项来自中国的大样本研究
Front Cardiovasc Med. 2021 Oct 4;8:736466. doi: 10.3389/fcvm.2021.736466. eCollection 2021.
2
An optimal window of platelet reactivity by LTA assay for patients undergoing percutaneous coronary intervention.经皮冠状动脉介入治疗患者通过光比浊法测定血小板反应性的最佳窗口期。
Thromb J. 2021 Oct 19;19(1):73. doi: 10.1186/s12959-021-00323-5.
3
Platelet Aggregometry Testing: Molecular Mechanisms, Techniques and Clinical Implications.
血小板聚集检测：分子机制、技术及临床意义
Int J Mol Sci. 2017 Aug 18;18(8):1803. doi: 10.3390/ijms18081803.
4
Tailored antiplatelet therapy in high-risk ACS patients treated with PCI stenting: lessons from the ANTARCTIC trial.经皮冠状动脉介入治疗（PCI）支架置入术治疗的高危急性冠状动脉综合征（ACS）患者的个体化抗血小板治疗：来自南极试验的经验教训。
J Thorac Dis. 2017 May;9(5):E440-E443. doi: 10.21037/jtd.2017.04.46.
5
Personalized antiplatelet therapy with P2Y12 receptor inhibitors: benefits and pitfalls.使用P2Y12受体抑制剂的个性化抗血小板治疗：益处与陷阱
Postepy Kardiol Interwencyjnej. 2015;11(4):259-80. doi: 10.5114/pwki.2015.55596. Epub 2015 Jan 12.
6
Platelet function testing in contemporary clinical and interventional practice.当代临床与介入实践中的血小板功能检测
Curr Treat Options Cardiovasc Med. 2014 May;16(5):300. doi: 10.1007/s11936-014-0300-y.
7
Genotypic and phenotypic assessment of platelet function and response to P2Y12 antagonists.血小板功能和对 P2Y12 拮抗剂反应的基因表型和表型评估。
Curr Cardiol Rep. 2011 Oct;13(5):439-50. doi: 10.1007/s11886-011-0208-z.
8
Personalized antiplatelet therapy: review of the latest clinical evidence.个体化抗血小板治疗：最新临床证据综述。
Curr Cardiol Rep. 2011 Aug;13(4):296-302. doi: 10.1007/s11886-011-0194-1.
9
Is platelet inhibition due to thienopyridines increased in elderly patients, in patients with previous stroke and patients with low body weight as a possible explanation of an increased bleeding risk?老年患者、既往卒中患者和低体重患者的噻吩吡啶类药物抑制血小板作用是否增强，是否可以解释出血风险增加？
Neth Heart J. 2011 Jun;19(6):279-84. doi: 10.1007/s12471-011-0105-5.